Belgian Consul General Visits Yuehai Subdistrict; RuiXin Medical Showcases Cardiovascular Precision Diagnosis and AI Robotic Intervention Platform
RaysightMed
Medical Imaging Product Developer
On October 21, 2025, Mr. Wim PEETERS (Wim Peeters), the Belgian Consul General in Guangzhou, along with other foreign officials and corporate representatives, visited the Yuehai Street area. They toured the Yuehai International Enterprise Service Exchange Center. RaysightMed, as a representative technology company within the Yuehai Street jurisdiction, was invited to attend. The company showcased its cutting-edge achievements in the field of cardiovascular precision diagnosis and treatment to international guests and engaged in in-depth discussions on technological innovation and international cooperation.
At the event, Chen Yan, Assistant to the General Manager of RaysightMed, gave a special presentation on the company's development history and core products. RaysightMed was founded inDecember 2017, isRaysightMed, a leading company in cardiovascular functional diagnostics, is committed to building an integrated precision diagnosis and treatment platform of "AI for cardio-cerebrovascular + surgical robot".PlatformThe company has completed five rounds of financing, with investments from well-known institutions such as Guoke Jiahe, Huachuang Capital, Matrix Partners, Tencent, and SDIC Venture Capital. The company currently holds 11 NMPA certificates and 1 EU CE certificate, with over 200 patents applied for and granted. It has clinical cooperation partnerships with more than 800 hospitals and over 50 research collaborations on its products, achieving safe usage by more than 200,000 patients.
At the exchange site, Chen Yan mainly introduced RaysightMed Score to foreign guests (RuiXin-FFR), AngioQFA, and a fully automatic AI vascular interventional surgical robot. RuiXin-FFR is based on coronary CT imaging, utilizing AI and three-dimensional computational fluid dynamics to achieve non-invasive FFR assessment.The world's first morphology + function integrated assessment platform to simultaneously obtain China NMPA and EU CE certification, with an accuracy rate of 92%, effectively reducing the risk of missed diagnosis and misdiagnosis.。
AngioQFA is a one-stop coronary function assessment system for macro FFR + micro IMR.One analysis synchronously obtains FFR and IMR with over 95% accuracy, supporting plaque assessment and surgical planning, adaptable to complex lesion types.。
RaysightMed Fully AutomaticAI Vascular Intervention Surgical Robot Based on“MedLife—"Intelligent System—Execution Terminal" Tripartite Collaboration: AI-driven surgery through doctors' voice commands, adopting a master-slave separated design to achieve sub-millimeter control of guidewires/catheters, combined with force feedback and 5G remote capabilities, completes operations such as balloon dilation and stent implantation while reducing radiation risks.
The three major products have achieved deep synergy,Formation"Non-invasive Diagnosis - Intraoperative Navigation - Precise Execution" Full-process Cardiovascular Diagnosis and Treatment Intelligent Closed-loop: RaysightMed-FFR Preoperative Functional Screening to Lock Lesions — AngioQFA Virtual Stent Simulation for Surgical Planning — Fully Automatic AI-Guided Vascular Intervention Robotic Precision Execution.
After the sharing session, the delegation from the Consulate General of Belgium in Guangzhou showed keen interest in RaysightMed. Both parties engaged in an in-depth exchange regarding the market environment and regulatory standards for medical devices in Europe.RaysightMed's Investment Director Hua Feng revealed: "RaysightMed is committed to becoming a global leader in AI + surgical robotics. CurrentlyRuiXin-FFR (RaysightMed-FFR)It has been approved for CE certification, and the company is also applying for more CE MDR registrations. Europe is an important target market for RaysightMed, and we look forward to working with more partners to bring Chinese products to the world."
Consul General Pei Weimin stated:"Breakthroughs in China's Medical Technology Are Exciting; Belgium Looks Forward to Becoming a Bridge Connecting Innovation Between China and Europe"。”Belgian Consulate General in GuangzhouExpressed high appreciation for RaysightMed's leading original technology, and was amazed by its AI + surgical robot pipeline layout. After full communication, they indicated that they would continue to stay in touch and actively seek potential cooperation opportunities.
This exchange not only showcased the innovative vitality of Yuehai Street as an international enterprise cluster but also provided an important opportunity for RaysightMed to expand international cooperation and promote China's intelligent cardiovascular precision diagnosis and treatment solutions globally.
